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Schistosomiasis and trichuriasis are two of the most common neglected tropical diseases (NTD) that 
affect almost a billion people worldwide. There is only a limited number of effective drugs to combat 
these NTD. Medicinal plants are a viable source of parasiticides. In this study, we have investigated 
six of the 19 phytochemicals isolated from two Bhutanese medicinal plants, Corydalis crispa and 
Pleurospermum amabile, for their anthelmintic properties. We used the xWORM technique and Scanning 
Electron Microscope-based imaging to determine the activity of the compounds. Of the six compounds 
tested, isomyristicin and bergapten showed significant anthelmintic activity against Schistosoma mansoni 
and Trichuris muris with bergapten being the most efficacious compound one against both parasites  
(S. mansoni IC50 = 8.6 μg/mL and T. muris IC50 = 10.6 μg/mL) and also against the schistosomulum stage 
of S. mansoni. These two compounds induced tegumental damage to S. mansoni and affected the cuticle, 
bacillary bands and bacillary glands of T. muris. The efficacy against multiple phylogenetically distinct 
parasites and different life stages, especially the schistosomulum where praziquantel is ineffective, 
makes isomyristicin and bergapten novel scaffolds for broad-spectrum anthelmintic drug development 
that could be used for the control of helminths infecting humans and animals.
Schistosomiasis and trichuriasis are major contributors to the disease burden in both humans and domestic ani-
mals, affecting the social and economic progress of many developing countries1–3. There are no vaccines, and only 
a handful of anthelmintic drugs exist to treat these infections. The development of drug-resistant helminths of 
livestock has been reported, and there is a looming threat of resistance for the few human drugs that are currently 
used in mass drug administration programs in developing countries4–6. This has necessitated the discovery of lead 
compounds and development of new anthelmintic drugs.
Natural products, especially medicinal plants, have a bewildering diversity of allelochemicals with unusual 
structures and have been a reliable source of chemotherapeutic moieties7, including for anthelmintic drug dis-
covery. For example, artemisinin and its derivatives (artemether) isolated from the Chinese medicinal plant, 
Artemesia annua, have a unique trioxane structure that is an essential frontline antimalarial drug which also has 
anti-schistosome and anti-cancer properties8–9. Another new antimalarial drug lead candidate, simplicifolianine, 
has been discovered from Meconopsis simplicifolia10. Despite their proven reputation as a source of antimalar-
ials, plants have been relatively under-explored as a source of anthelmintic compounds. Athanasiadou et al.11 
described a number of plants with anthelmintic properties under controlled experimentation, either through 
feeding of whole plant or plant extracts to parasitised hosts. While some plant extracts have strong bioactivi-
ties, even against drug-resistant worms, the use of crude extracts is fraught with complexity in terms of dose 
standardisation and mechanism of drug action. Crude plant extracts contain mixtures of allelochemicals, which 
may have synergistic, antagonistic or even superimposed bioactivities. For this reason, isolating, quantifying and 
identifying the bioactive compounds in plant extracts is a prerequisite for drug discovery and will accelerate the 
development of new generations of anthelmintic compounds.
Drawing inspiration from Bhutanese traditional medicine (BTM) we explored the anthelmintic properties 
of two medicinal plants – Corydalis crispa and Pleurospermum amabile, against S. mansoni and T. muris. These 
Centre for Biodiscovery and Molecular Development of Therapeutics, Australian Institute of Tropical Health and 
Medicine, James Cook University, Cairns, QLD, Australia. Correspondence and requests for materials should be 
addressed to P.W. (email: phurpa.wangchuk@jcu.edu.au)
received: 13 May 2016
Accepted: 02 August 2016
Published: 30 August 2016
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 6:32101 | DOI: 10.1038/srep32101
plants have been traditionally used in BTM as cleansing and detoxification agents, and also in treating liver dis-
ease, dyspepsia and other gastrointestinal infections that bear relevance to parasitic diseases12. The bitter root 
of C. sempervirens, which is a close relative of C. crispa, is also used as an anthelmintic and emmenagogue13. 
Ecologically, these plants have been observed to avoid attack from insects, indicative of their anti-feedant prop-
erties. The crude extracts and a small number of isolated compounds from C. crispa and P. amabile have been 
reported to have anti-parasitic activities against Trypanosoma brucei rhodesiense12 and the multi-drug resistant 
strain (K1CB1) of Plasmodium falciparum14–15. However, none of the 19 compounds isolated from these two 
plants were previously investigated for efficacy against parasitic helminths. This lead information provided strong 
rationale for screening six major compounds isolated from C. crispa and P. amabile against the two most impor-
tant genera of human helminth parasites, the nematode whipworm (Trichuris) and the platyhelminth blood fluke 
(Schistosoma). Other minor compounds were not studied here due to limited quantities isolated at the time of 
our phytochemical analysis. We used the xWORM technique16 that monitors helminth motility in real time using 
xCELLigence to investigate their anthelmintic activities and further demonstrated the promising efficacy of ber-
gapten and isomyristicin using scanning electron microscopy (SEM) techniques.
Results
Preparation of phytochemicals for the study. In this study, compounds isolated from two different 
Bhutanese medicinal plants, Corydalis crispa and Pleurospermum amabile, were investigated for their anthel-
mintic activities. Focusing on alkaloids, the MeOH extract of C. crispa was sequentially fractionated and extracted 
using different solvents of increasing polarities, which finally yielded 1.34 g of crude total alkaloids. This crude 
alkaloid extract was purified using fractional crystallization and separation techniques as detailed in the Materials 
and Methods section. Through repeated separation by flash column chromatography and pre-coated silica 
plates, a total of nine isoquinoline alkaloids were isolated and characterised from C. crispa14 using Infrared (IR) 
Spectroscopy, Mass Spectrometry (ESI-MS, HR-EI-MS), Gas Chromatography Mass Spectrometry (GCMS), and 
Nuclear Magnetic Resonance (NMR-1H, 13C, gCOSY, gNOESY, TOCSY, gHSQC and gHMBC). Similarly, the 
crude MeOH extract of P. amabile was subjected to acid-base fractionation and repeated separation processes 
using the same techniques described above for C. crispa, which finally yielded four phenylpropanoids and six 
furanocoumarins15,17.
Out of 19 phytochemicals isolated in total from these two plants, six major compounds (1–6) were selected 
(Fig. 1) and screened them for their anthelmintic activities using the xWORM technique. The quantities of 
other minor compounds that we have isolated from these two plants were insufficient for carrying out any form 
of anthelmintic analyses. The selected compounds were: protopine (1), 13-oxoprotopine (2), ochrobirine (3), 
isomyristicin (4), bergapten (5) and isoimperatorin (6). Their structures are drawn in Fig. 1. While compounds 
1–3 were isolated from C. crispa, compounds 4–6 were isolated from P. amabile.
Trematocidal effects of compounds 1–6 against Schistosoma mansoni adult flukes. Seven weeks 
post-infection, adult flukes were perfused from the mesenteries of mice and transferred immediately to Basch 
Figure 1. Structures of the compounds (1–6) isolated and screened for their anthelmintic activities. (A) 
Protopine (1), 13-Oxoprotopine (2) and ochrobirine (3) were isolated from Corydalis crispa14. (B) Isomyristicin 
(4), bergapten (5) and isoimperatorin (6) were isolated from Pleurospermum amabile15.
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medium (10% fetal bovine serum and 1 × penicillin/streptomycin) for culturing at 37 °C with 5% CO2. After an 
overnight incubation at these conditions, the parasites were transferred to E-plates for drug treatments and their 
motility/mortality were monitored using the xWORM technique16. Among the six compounds (1–6, Fig. 1) tested 
here, none of the three compounds (1–3) isolated from C. crispa exhibited any substantial anti-Schistosoma effects. 
However, two compounds – isomyristicin (4) and bergapten (5), which were isolated from P. amabile, showed 
significant dose-dependent activity against S. mansoni adult flukes (Fig. 2A) with IC50 values of 52.0 μg/mL 
and 8.6 μg/mL, respectively (calculated at 12 h post addition of compounds). While the highest doses (1000 μg /mL) 
of both compounds killed flukes within 12 h, the lower doses (0.1–10 μg/mL) took longer to kill flukes as reflected 
by higher motility index values (Fig. 2A). Of the compounds assessed, bergapten exhibited significantly greater 
anti-schistosome activity at all time points with IC50 values of 10.2 μg/mL (1 h), 16.0 μg/mL (6 h) and 8.6 μg/mL 
(12 h) (Fig. 2B).
Effects of isomyristicin and bergapten against schistosomula of S. mansoni. Praziquantel is effec-
tive against adult stage schistosomes but not against the intra-mammalian larval stage of S. mansoni – the schisto-
somulum. Since isomyristicin and bergapten showed significant anti-schistosome effects against adult flukes, we 
tested them against the schistosomulum stage. Schistosomula were generated by mechanical transformation of 
cercariae as described by Peak et al.18 and 100 of them were placed in each well of a 96 well plate containing culture 
media (100 μL). These schistosomula were co-cultured in the presence of the two compounds and were assessed 
for their survival using Trypan blue exclusion (Fig. 3A). Isomyristicin and bergapten showed lethal effects at a 
lowest dilution of 60 μg/mL and 16 μg/mL, respectively, achieving 85–100% killing (Fig. 3A). A dose response 
curve of schistosomula survival showed that bergapten with an IC50 of 100.3 μg/mL was marginally more potent 
than isomyristicin with an IC50 of 150.5 μg/mL (Fig. 3B). Schistosomula treated with 1% DMSO in culture media 
(as solvent control) showed no signs of toxicity or death (100% survival) as measured by Trypan blue exclusion.
SEM analysis of S. mansoni treated with isomyristicin and bergapten. Based on the best in vitro 
anthelmintic activity exhibited by isomyristicin and bergapten, we further investigated the effects of these com-
pounds on the morphology of adult S. mansoni using SEM. The effect of praziquantel (used as positive control 
here) on the S. mansoni tegument has been assessed using SEM19. The SEM samples were prepared in triplicates 
by dividing the 24 well plates into three groups. We observed that isomyristicin, bergapten and praziquantel 
affected the morphology of adult worms in a dose dependent manner. The representative SEM photos of different 
treatment groups (all groups treated with 4 μg/mL doses) shown in Fig. 4 demonstrate the observed physiological 
and tegumental changes. Worms cultured in media only (with 1% DMSO in culture media as vehicle control) 
displayed normal physical appearance (Fig. 4A) with numerous healthy tubercles and well-formed spines in males 
(Fig. 4B), and clearly defined surface grooves with sensory papillae in females (Fig. 4C). On the other hand, the 
male S. mansoni that were treated with isomyristicin, while not displaying a coiled appearance (Fig. 4D), did show 
signs of eroded tubercles and loss of spines and formation of cracks (marked with red arrow) in the dorsal surface 
of the tegument (Fig. 4E).
The female worms treated with the same compound exhibited partially coiled physical appearances, and 
at higher SEM magnification the damage to the sensory papillae in the female tegument (Fig. 4F) was visible. 
Figure 2. Anti-schistosome activities of six compounds (1–6) against adult Schistosoma mansoni determined 
using the xWORM technique. (A) Motility/mobility index dose response curves of worms 12 h after addition of 
test compounds at different doses (0.1–1000 μg/mL). (B) 50% inhibitory concentration (IC50) curves over time. 
Error bars represent 95% confidence intervals of the nonlinear curve fit. The curves were marginally shifted on 
the x-axis to aid viewing. These figures represent the data from three independent experiments.
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Bergapten-treated parasites displayed more extensive physical and morphological changes (Fig. 4G–I). Both male 
and female worms showed a coiled appearance (Fig. 4G). Male worms suffered from disfigurement of oral and 
ventral suckers (Fig. 4H), erosion of tubercles (Fig. 4H, inset photo), loss of spines and formation of cracks/holes 
in the dorsal surface of the tegument (Fig. 4H, inset photo). The female worms exhibited erosion of the tegument 
and sensory papillae (Fig. 4I, inset photo). Similarly, praziquantel-treated parasites displayed far more extensive 
morphological changes (Fig. 4J–L). The degree of coiling (Fig. 4J) and the tegumental damage caused by prazi-
quantel were visually apparent, as was that caused by bergapten and isomyristicin, which suggests that these 
compounds acted to damage the tegument in similar fashion.
Nematocidal effects of compounds 1–6 against Trichuris muris adult whipworms. After 
four weeks, adult worms were harvested from the caecum of the mice, washed with PBS/2 × antibiotic/anti-
mycotic (AA), resuspended in culture medium (100 μL of RPMI containing 10% foetal calf serum and AA), 
transferred four worms each in the E-Plates and then incubated overnight at 37 °C with 5% CO2. These worms 
were co-cultured with compounds 1–6 at same conditions and their motility/mortality were assessed using the 
xWORM technique16. Of the six compounds (1–6, Fig. 1) tested, isomyristicin and bergapten again showed 
the best dose-dependent anti-Trichuris activity with IC50 values of 20.9 μg/mL and 10.6 μg/mL, respectively – 
calculated on cell motility index at the 12 h time point (Fig. 5A). The IC50 values of the six compounds tested 
were obtained using xWORM and calculated at 1 h, 6 h and 12 h time points (Fig. 5B). At 1 h post-treatment 
intervals, isomyristicin-treated worms appeared to be active even at the highest dose administered. However, 
by 6 h post-treatment, worm motility rapidly declined with an IC50 value similar to that of bergapten (Fig. 5B). 
Bergapten exhibited the best IC50 values (8.6–16.0 μg/mL) at 1 h and 12 h time points in comparison to other 
compounds tested.
SEM analysis of T. muris treated with isomyristicin and bergapten. Based on the anti-Trichuris 
activity of isomyristicin and bergapten (determined using xWORM), we analysed the effect of drug treatment 
on the morphology of T. muris using SEM. T. muris (mixed sexes) treated with culture media (1% DMSO) alone 
showed normal anterior body appearance (Fig. 6A) with well defined bacillary glands (Fig. 6B) and a smooth 
cuticle with knitted parallel segmental joins (Fig. 6C). On the other hand, the worms treated with isomyristicin 
(Fig. 6D–F) exhibited partial damage to the morphology of worms including swelling, loosening and destruc-
tion of bacillary glands and the cuticle. Bergapten (Fig. 6G–I) affected worm morphology in a similar way. 
Mebendazole-treated worms (Fig. 6J–L) (positive control) showed a higher degree of bacillary gland damage and 
cuticular fissures compared to the two test samples.
Discussion
New drugs can be developed synthetically. However, the natural products, especially those compounds derived 
from medicinal plants including quinine and artemisinin, continue to save the lives of millions of people world-
wide. Despite this proven record, medicinal plants have been relatively under-explored as a source of anthelmintic 
compounds. We have recently reported the anti-parasitic activities of the crude extracts and a small number 
of isolated compounds from the Bhutanese medicinal plants, C. crispa and P. amabile, against Trypanosoma 
brucei rhodesiense and the multi-drug resistant strain (K1CB1) of Plasmodium falciparum12,14–15. Encouraged 
Figure 3. Effect of isomyristicin and bergapten on the survival of S. mansoni schistosomula. (A) Trypan 
blue stained images (20×) showing 100% lethality to schistosomula (250 μg/mL compound concentrations) and 
first signs of lethal effects observed at 31.2 μg/mL of the two compounds tested. Deep blue staining signifies a 
dead parasite. (B) The effect of the two compounds on schistosomula survival at different concentrations  
(250–1.95 μg/mL). The data was generated from triplicate samples obtained from two independent studies.
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by this report and also the traditional uses of the plants as anthelmintics12–13, we have further investigated six 
major compounds (out of 19 compounds isolated in total) against two distinct phyla of helminth parasites, the 
soil-transmitted nematode T. muris and the platyhelminth S. mansoni. We found that two of them – isomyristicin 
and bergapten that were isolated from P. amabile – have dual anthelmintic properties.
Isomyristicin and bergapten exhibited dose-dependent lethal effects against S. mansoni with IC50 values of 
52.0 μg/mL and 8.6 μg/mL, respectively – which were calculated on cell motility index at the 12 h time point. At 
the lowest dilution of 60 μg/mL and 16 μg/mL – respectively, both compounds achieved 85–100% killing of schis-
tosomula – the developmental stage to which praziquantel is ineffective. Isomyristicin and bergapten also demon-
strated anti-Trichuris activity with IC50 values of 20.9 μg/mL and 10.6 μg/mL, respectively. Since mebendazole and 
albendazole are still effective in controlling the infective embryonic stage of whipworm, we did not see a need 
to screen them here. The ultrastructural analysis of worms treated with these two compounds revealed similar 
patterns of surface damage to those induced by praziquantel and mebendazole20–23. The surface damage inflicted 
by these two compounds resulted in coiled and shrivelled phenotypes with surface erosions at the time of death. 
In T. muris, the test compounds induced physical damage mainly around the anterior bacillary band and glands, 
which are responsible for excretion of digestive enzymes, pre-digestion and nutrient uptake24–27. In S. mansoni, 
both compounds damaged spines giving rise to a pitted appearance with holes/pores around the tubercles.
We expected that the broad-spectrum properties of these two compounds could be linked to their cytotoxicity 
profiles. However, our previous cytotoxicity evaluation15 showed that both compounds had negligible toxicity pro-
files. Interestingly, myristicin (parent chemical from which isomyristicin is derived) and bergapten are both com-
ponents of vegetables/herbs/fruits consumed by humans on a daily basis. For example, parsley, celery, lemons, figs, 
Figure 4. Scanning electron micrographs showing the surface morphology of S. mansoni treated with 
solvent alone, isomyristicin, bergapten and praziquantel. The SEM photos represent different groups treated 
with the lowest dose concentration of 4 μg/mL (all inset photos are 1 μm). (A–C) Worms cultured in solvent alone 
(1% DMSO/culture media) displayed a relaxed (uncoiled) and healthy physical appearance. (D–F) Isomyristicin 
treated parasites displayed a partially damaged physical appearance including erosion of tubercles (E), loss of 
spines and cracks (marked with red arrow) in the dorsal surface of the tegument (E, inset photo), and damage to 
the sensory papillae in the female tegument (F, inset photo). (G–I) Bergapten-treated parasites displayed a coiled 
appearance with similar damage to the worm teguments including erosion of tubercles (H) and loss of spines and 
cracks (marked with red arrow) on the dorsal surface of the tegument (H, inset photo), and damage to the sensory 
papillae in the female tegument (I, inset photo). Similar patterns but with extensive morphological changes were 
seen in the praziquantel-treated parasites (J–L).
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carrots, grape juice, Earl grey tea, nutmeg, and dill have all been reported to contain these two phytochemicals28–33, 
albeit at very low concentrations. For example, the quantity of bergapten that can be ingested during a regular meal 
containing parsley is approximately 0.5–0.8 mg33. Thus, the likelihood of an anthelmintic benefit from dietary intake 
is low. Our readings of the published literature revealed little bioactivity information on isomyristicin, but bergapten 
has been subjected to a number of biological studies. Bergapten is reported as an effective molluscidal agent against 
Biomphalaria glabrata (wrongly reported as B. boissi by Schonberg and Latif in 1954)34 – an intermediate host of 
S. mansoni and is neither caustic nor irritating, as is the case with many synthetic molluscicides. Bergapten is also a 
known photomutagenic and phototoxic agent and is applied in sunscreens and in tanning cosmetic products to stim-
ulate skin pigmentation35. It has been clinically studied in photochemotherapy of psoriasis, where patients treated 
with 1.2–1.6 mg/kg oral dosing experienced therapeutic benefits without side effects36. It has been also proposed as 
an active molecule to counteract survival and growth of breast hormone-responsive tumors possibly due to inhibi-
tion of cytochrome activities30,37. While these therapeutic properties of bergapten are encouraging, it has also been 
reported as a selective axolemmal potassium channel blocker38 prompting a need for further substantiatsion of its 
therapeutic value versus toxicity index using appropriate in vivo models.
Finding new anthelmintic drug lead compounds, both from natural and synthetic sources, has become crucial 
since there are only limited anthelmintic drugs available to combat schistosomiasis and soil-transmitted helminth 
infections, which together affect more than one billion people worldwide1–3. The poor cure rates described for 
both praziquantel and albendazole and the development of resistance to most anthelmintics used to treat live-
stock39 is a concern given the sole reliance on mass drug administration programs for human NTDs. Moreover, 
efforts to develop vaccines against parasitic platyhelminths and nematodes have thus far been unsuccessful, pre-
cipitating an urgent need to find arrays of new anthelmintic drug lead molecules that can be developed into 
more effective anthelmintics. New anti-parasitic drugs require excellent safety and therapeutic profiles, should 
exhibit broad spectrum activity against different types of infections, and also display significant activity against 
different developmental stages of parasites40. Therefore, finding a broad-spectrum drug that could treat multiple 
diseases or multiple life stages is desirable, especially in developing countries with limited resources. Isomyristicin 
and bergapten met these criteria in that they have anti-fluke and anti-whipworm properties. In addition, these 
compounds were effective at killing schistosomula, the stage of S. mansoni where the existing frontline drug 
praziquantel is ineffective. This anti-schistosomulum activity of the two compounds is interesting and warrants 
in-depth therapeutic analysis. Effectively controlling the early stages of infection in the human (host) prior to 
the onset of egg laying could prevent further damage to the lung and liver, thereby preventing the maturation of 
larvae into adult flukes that lodge in the portal and mesenteric vasculature.
In summary, despite their anthelmintic activity being significantly better than the untreated control group, 
the therapeutic effects of isomyristicin and bergapten were markedly weaker than praziquantel and mebendazole. 
However, unlike praziquantel or mebendazole, isomyristicin and bergapten showed widespread anti-parasitic 
properties – especially against the infective schistosomulum stage of S. mansoni. Both compounds met the criteria 
of the ‘Lipinski rule of 5’41,42, which predicts the drug-likeliness of a compound based on the bioavailability or 
membrane permeability of a chemical to an organism. They are small molecules with molecular weights less than 
500 atomic mass units and have large log P values of 2–3, which enhance the compound permeability into the cell 
Figure 5. Anti-Trichuris effects of compounds (1–6) against T. muris determined using the xWORM 
technique. (A) Effects of different concentrations of compounds 1–6 were assessed on adult worm motility. 
50% inhibitory concentration (IC50) values were determined at the 12 h time point. (B) Combined IC50 values of 
these six compounds calculated for three different doses at 1, 6, and 12 h time points. Error bars represent 95% 
confidence intervals of the nonlinear curve fit. The curves were marginally shifted on the x-axis to aid viewing. 
These figures represent the data from three independent experiments.
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membrane. All these chemical and biological properties of isomyristicin and bergapten highlight their potential 
as lead scaffolds upon which to develop newly derivatized anthelmintic drugs. With further medicinal chemistry 
optimisation, including derivitization, drug structure-activity-relationship and detailed cytotoxicity studies, these 
two compounds offer promise as natural product anthelmintics against various life stages of multiple phylogenet-
ically distant parasites - blood flukes and whipworms -, which cause some of the most crippling and debilitating 
human tropical diseases.
Materials and Methods
Plant materials and preparation of compounds for anthelmintic assay. The whole part of wild 
Corydalis crispa (Fumariaceae) and the aerial part of wild Pleurospermum amabile (Umbelliferae) were collected 
from alpine Himalayan mountains (altitude range of 3600–4800 meters above sea level) of Lingzhi in Bhutan in 
June–August 2009. They were assigned herbarium voucher specimen number 78 and 29, respectively; and were 
deposited at Menjong Sorig Pharmaceuticals (previously called Pharmaceutical and Research Unit), Ministry of 
Health in Bhutan. The air-dried plant materials (2 kg each) were chopped into small pieces and were repeatedly 
extracted with methanol (AR/HPLC grade, 5~ 3 L over 48 h) to obtain crude methanol extract of C. crispa (90 g) 
and P. amabile (190 g).
The isolation of alkaloids from the crude MeOH extract of C. crispa was performed as described previously14. 
The MeOH extract was acidified with HCl (5%) and then subjected to sequential fractionation and extraction 
using hexane (5 × 60 mL) and CH2Cl2 (5 × 60 mL). The remaining acidified aqueous solution was basified 
(pH 9–11) with NH4OH solution, then extracted with CHCl3 (5 × 60 mL). The CHCl3 extract was washed with 
Figure 6. Scanning electron micrographs showing the surface morphology of T. muris treated with solvent 
alone, isomyristicin, bergapten and mebendazole. The SEM photos represent different groups treated with 
the lowest dose concentration of 4 μg/mL. (A–C) Worms treated with solvent alone (1% DMSO/culture media) 
displayed an unremarkable phenotype with intact bacillary bands, glands and cuticle. Worms treated with 
isomyristicin (D–F), bergapten (G–I) and mebendazole (J–L) exhibited swelling, undulation and loosening 
of the cuticle surrounding the bacillary glands and cuticular fissures. The red arrows show the affected regions 
when treated with the compounds and positive control drug.
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H2O, dried with Na2SO4 and the solvent was evaporated under reduced pressure to yield a crude CHCl3 alkaloid 
extract (1.34 g). Focusing on alkaloids, the crude basic CHCl3 extract was subjected to the fractional crystallization 
and repeated separation and purification processes using flash column chromatography packed with Merck 
Kieselgel 60 PF254 and the pre-coated silica plates (0.2 mm silica thickness, Merck). Nine alkaloids were isolated 
from C. crispa14.
The isolation of phenylpropanoids and furanocoumarins from the crude MeOH extract of P. amabile was 
performed as described previously15. The crude extract was dissolved in MeOH/water (1:9) and fractionated first 
with petroleum spirit to remove fats and other neutral compounds. The remaining aqueous portion was acidified 
with HCl (5%) and fractionated with CH2Cl2 to remove acidic compounds. The aqueous component was again 
basified with NH4OH at pH 9–12 and then fractionated with CH2Cl2 to generate the basic CH2Cl2 extract–from 
which four phenylpropanoids and six furanocoumarins were isolated15,17 using column and thin layer chromat-
ographies as specified above.
These natural products isolation protocols used UV light (short wavelength of 254 nm, long wavelength of 
366 nm) and ceric ammonium molybdate (CAM) for visualization and detection of the compounds on TLC 
plates. Infrared (IR) Spectroscopy, Mass Spectrometry (ESI-MS, HR-EI-MS), Gas Chromatography Mass 
Spectrometry (GCMS), and Nuclear Magnetic Resonance (NMR-1H, 13C, gCOSY, gNOESY, TOCSY, gHSQC and 
gHMBC) were used for characterizing and identifying the isolated compounds. Out of 19 compounds isolated 
from these two medicinal plants14,15,17, we have selected six major compounds: protopine (1), 13-oxoprotopine 
(2), ochrobirine (3), isomyristicin (4), bergapten (5) and isoimperatorin (6), for screening their anthelmintic 
activities. The stock solutions of the six test compounds were prepared by initially dissolving 1 mg of weighed 
samples in 10–20 μL of DMSO and then subsequently diluting them with 980–990 μL of relevant culture media 
to make the stock concentrations of 1 mg/mL. While culturing the worms with 1 mg/mL dose concentrations, 
we transferred 20 μL of stock solutions into E-plate wells containing parasites in 180 μL of fresh media (without 
DMSO). The final volume in each well was 200 μL (20 μL test solutions + 180 μL of fresh media). To achieve other 
dose concentrations (0.1–200 μg/mL), we pre-diluted the stock solutions to make that required concentration and 
then added to the E-plates as performed in the initial dosing experiment. These were performed in triplicate with 
a final in-well compound concentration ranging from 0.1–1000 μg/mL. Each replicate contained solvent control 
(1% DMSO in culture media). For schistosomula drug assays, stock solutions were diluted in culture media with 
two-fold dilutions to obtain in-well dose concentrations of 2–1000 μg/mL.
Preparation of S. mansoni adult flukes. S. mansoni cercariae were shed from infected Biomphalaria 
glabrata snails (Biomedical Research Institute, MD, USA) by exposure to light at 26 °C for 2 h. BALB/c mice 
(12–14 weeks old male) were infected with cercariae (~120 cercariae/mouse) by abdominal penetration as 
reported previously43. Seven weeks post-infection, adult flukes were perfused from the mesenteries of mice and 
transferred immediately to Basch medium (10% fetal bovine serum and 1 × penicillin/streptomycin) for culturing 
at 37 °C with 5% CO2 as previously reported44. After an overnight incubation at 37 °C with 5% CO2 parasites were 
transferred to E-plates (ACEA Bioscience Inc., USA) for motility assessment using the xWORM technique or 
SEM, described below.
Schistosomula preparation. Schistosomula were generated by mechanical transformation of cercariae as 
described by Peak et al.18 Schistosomula (100 μL volume containing ~100 schistosomula) were placed in 96 well 
plates containing culture media (100 μL) and divided into triplicate wells for each compound. Parasites were 
treated with the test compounds at various in-well concentrations of 2–1000 μg/mL achieved through two-fold 
dilution. Parasites were cultured at 37 °C with 5% CO2 for 12–40 h and stained with trypan blue solution to assess 
viability after treatment. The live and dead flukes in each well were counted manually under a light microscope 
and 50% inhibitory concentration (IC50) values were calculated for each compound.
Preparation of adult Trichuris muris. Genetically susceptible mice were orally infected with approxi-
mately 200 T. muris eggs. After 4 weeks the mice were sacrificed and adult worms were harvested from the cae-
cum. The worms were washed with PBS/2 × antibiotic/antimycotic (AA), resuspended in culture medium (100 μL 
of RPMI containing 10% foetal calf serum and AA). After an overnight incubation at 37 °C with 5% CO2 parasites 
were transferred to E-plates (ACEA Bioscience Inc., USA) for motility assessment using the xWORM technique 
or SEM, described below.
xWORM technique. The xWORM technique was employed using an xCELLigence SP system (ACEA 
Biosciences Inc., USA) as described previously16,45. All experiments were carried out as per the manufacturer’s 
instructions with 15 sec read intervals using the real time cell assay (RTCA) software (ACEA Biosciences Inc., 
USA). Separated (single) and paired adult S. mansoni flukes per well (mixed gender) were used in the xWORM 
assay (two independent experiments), and four adult T. muris of mixed gender were placed in each well of the 
96 well E-plates containing a final volume of 200 μl of culture medium. All assays were conducted in triplicate. 
Inter-well spaces were filled with 100 μL of culture medium or PBS to prevent evaporation. The E-plates contain-
ing worms were cultured overnight at 37 °C with 5% CO2 to obtain a baseline motility reading. The worms were 
then treated with prepared concentrations of the test compounds and the motility of the worms was monitored 
for 12–40 h.
IC50 calculations and statistical analyses. As described previously16,45, we determined the IC50 values of 
test compounds based on the motility index for adult worms. The motility index was calculated as the standard 
deviation (SD) over 800 data points (i.e. 4 readings per min for 200 min) of the cell index (CI) difference from the 
rolling average over 20 data points (10 proceeding and preceding CI values - 5 min total). While 100% motility 
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was determined from the average motility index of the untreated wells, 0% motility was determined from a media 
only well (no worms present). The 100% motility was converted from the motility index averaged over 100 data 
points (25 min). This figure was then used in GraphPad Prism 6.0 to calculate and compare IC50 values. We used 
a log (test compound concentration) vs normalised response (100–0%) formula, with variable slope when data 
were sufficient or set −1 hill slope when data was limited, and outliers were automatically removed (with default 
ROUT coefficient used: Q = 1%). The IC50 values for each dose concentration were calculated at 1, 6, and 12 h 
post-treatment of the worms with the test compounds. Compounds with IC50 values of higher than 100 μg/mL 
were considered ineffective in this study. When data were sufficient to use the variable slope statistical analysis, 
the Hill Slope and the Log IC50 value were together compared for significant differences using an extra sum-of 
squares F-test of GraphPad Prism 6.0.
Scanning electron microscopy. Adult worms were treated with prepared concentrations of test com-
pounds. To determine how the compounds impacted on the morphology of adult worms, we used modified 
SEM methods detailed in Stepek et al.22. For S. mansoni, we used the methods described by Edwards et al.21. 
Mebendazole was used as a positive control for anti-Trichuris activity and praziquantel was used as a positive 
control for anti-Schistosoma activity. Treated worms were prepared for SEM as follows: a) fixed in gluteraldehyde 
(3%) in Sorensen’s buffer overnight; b) dehydrated (15 min each) with a graded ethanol series (50%, 60%, 70%, 
80%, 90%, 100%), mixture of ethanol and hexamethyldisilizane (HMDS) (1:1 ratio), and then finally with pure 
HMDS (100%); c) dried overnight in a fume hood. Two or three dried worms from each treatment regimen 
were placed on an aluminum stub, sputtered with gold and then visualized using a JEOL JSM scanning electron 
microscope (10 kV). To assess the morphological changes, we scanned each worm from anterior to posterior and 
obtained digital images of the affected region using Semaphore software.
Ethics and clearances.  All experimental work involving mice was approved by the James Cook University 
(JCU) animal ethics committee (Ethics approval number A2213). Mice infected with S. mansoni and T. muris 
were raised in cages at the JCU animal facility under normal conditions of regulated temperature (22 °C) and 
lighting (12 h light/dark cycle) with free access to pelleted food and water. The mice were kept for 4–7 weeks in 
cages in compliance with the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes, 
7th edition, 2007 and the Queensland Animal Care and Protection Act 2001.
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